Interventional Oncology Devices | Market Insights | Europe (Supplemental) | 2022
While the COVID-19 pandemic will have a negative, albeit relatively limited, impact on European interventional oncology device market in the short term, the market will grow modestly over the forecast period, driven by an expanding patient population, improved reimbursement leading to adoption of premium-priced devices, and increased physician training on interventional oncology procedures. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints in the region.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Europe across a 11-year period.
